StockMarketWire.com - Inflammation and oncology focused Tiziana Life Sciences said it had appointed advisers in relation to a planned redomicile to Bermuda that would see its shares delisted from AIM.
The move was expected to occur in the second quarter of 2020, the company said.
Tiziana also said it intended to cancel its American depository receipt program and have its Bermuda common shares listed on the Nasdaq exchange.
At 9:18am: [LON:TILS] Tiziana Life Sciences Plc share price was -24p at 27.5p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.